Jeffrey Weiss’ thirty-five-year tenure in the financial services industry has provided him with an in-depth knowledge of trading, risk management, capital raising, capital structures, relationships with investors and businesses, and building strong management teams.

‍

Jeff joined Lehman Brothers in 1983 following graduation from the University of Wisconsin – Madison. During his twenty-five-year career with the firm, he sat on the firm’s Management Committee, Fixed Income Executive Committee, and Investment Bank Investment Committee. Jeff began his career in Fixed Income, where he managed risk and held various leadership roles. After spending 15 years in Fixed Income, he was given the responsibility to merge all origination businesses firmwide. The division he ultimately led, Global Finance, was responsible for creating, structuring, and distributing all financial products. Businesses that were housed inside of Global Finance included Investment Grade Debt, High Yield Debt, Bank Loans, Securitized Products, Corporate Derivatives including Foreign Exchange and all Equity origination. After leading Global Finance for five years, he was asked to create a firmwide Financial Institutions business that included Investment Banking and partnering with the firm's Principal businesses. Following Lehman Brothers, Jeff spent three years at Barclays Capital running the firm’s Global Financial Institutions Investment Banking Group.

‍

Jeff parlayed his decades-long experience structuring products and underwriting transactions to managing a single-family office. He specializes in investing globally across asset classes, including real estate equity and debt, mezzanine and structured debt, venture capital, and private equity. This venture led him to partner with longtime friend and colleague, Perry Hoffmeister, to found Colter Lewis.

‍

Jeff is the lead independent director and audit committee chair at Eagle Point Credit Company (NYSE: ECC) and Eagle Point Income Company (EIC). A committed volunteer and philanthropist, he has most recently been a member of the board of City Harvest for nearly fifteen years, holding its Treasurer position for eight. He is currently a member of the Abramson Cancer Center Innovation advisory board at Penn Medicine and has been funding immunotherapy research at Memorial Sloan Kettering Hospital Weill Cornell and Penn Medicine.

Jeff Weiss